Drug Profile
Research programme: small molecule therapeutics - ChemDiv/Janssen
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator ChemDiv; Janssen Pharmaceutica; Tibotec Pharmaceuticals
- Developer ChemDiv; Janssen Pharmaceutica; Janssen R&D Ireland
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Undefined in Russia
- 16 Jul 2016 No recent reports of development identified for research development in Undefined in USA
- 20 Dec 2011 Early research in Undefined indication in Russia (unspecified route)